Daniel Bondeson to Protein Kinase Inhibitors
This is a "connection" page, showing publications Daniel Bondeson has written about Protein Kinase Inhibitors.
Connection Strength
0.673
-
Bondeson DP, Smith BE, Burslem GM, Buhimschi AD, Hines J, Jaime-Figueroa S, Wang J, Hamman BD, Ishchenko A, Crews CM. Lessons in PROTAC Design from Selective Degradation with a Promiscuous Warhead. Cell Chem Biol. 2018 01 18; 25(1):78-87.e5.
Score: 0.525
-
Burslem GM, Schultz AR, Bondeson DP, Eide CA, Savage Stevens SL, Druker BJ, Crews CM. Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation. Cancer Res. 2019 09 15; 79(18):4744-4753.
Score: 0.148